REGULATORY COMPLIANCE AND METHOD VALIDATION - Flow Cytometry in Drug Discovery and Development - page 256

24. Code of Federal Regulations Title 21 Part, 312. Investigational new drug application. Fed.
Regist. 2009;74:68750. Available at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/
cfcfr/CFRSearch.cfm?CFRPart ¼ 312&showFR ¼ 1.
25. ICH. International Committee for Harmonization (ICH) of Technical Requirements for
Registration of Pharmaceuticals for Human Use. ICH Topic E6 (R1) Guideline for Good
Clinical Practice (GCP), 2002. Available at http://www.emea.europa.eu/pdfs/human/ich/
013595en.pdf.
26. ICH. International Conference on Harmonization of Technical Requirements for
Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite, 2009.
Available at http://www.ich.org.
27. Lee JW, Weiner RS, Sailstad JM, Bowsher RR, Knuth DW, O'Brien PJ, Fourcroy JL, Dixit
R, Pandite L, Pietrusko RG, Soares HD, Quarmby V, Vesterqvist OL, Potter DM, Witliff
JL, Fritche HA, O'Leary T, Perlee L, Kadam S, Wagner JA. Method validation and
measurement of biomarkers in nonclinical and clinical samples in drug development: a
conference report. Pharm. Res. 2005;22(4):499-511.
28. Stiles T, Grant V, Mawbey N. Good Clinical Laboratory Practice (GCLP): A Quality
System for Laboratories which Undertake the Analyses of Samples from Clinical Trials.
British Association of Research Quality Assurance, Ipswich, UK, 2003, pp. 1-17.
Available at http://www.barqa.com/.
29. Sarzotti-Kelsoe M, Cox J, Cleland N, Denny T, Hural T, Needham L, Ozaki D, Rodrigues-
Chavez IR, Stevens G, Stiles T, Tarragona-Fiol T, Simkins A.Evaluation and
recommendations on good clinical laboratory practice guidelines for phase I-III
clinical trials: PLOS medicine guidelines and guidance 6(5) e1000067, 2009.
Available at http://www.plosmedicine.org.
30. Department of Health and Human Services, NIH. DAIDS Guidelines for Good Clinical
Laboratory Practice Standards. N01-AI-50022, 2008. Available at http://www3.niaid.nih.
gov/LabsAndResources/resources/DAIDSClinRsrch/PDF/GCLP.pdf.
31. Ezzelle J, Rodriguez-Chavez IR, Darden JM, Stirewalt M, Kunwar N, Hitchcock R, Walter
T, D'Souza MP. Guidelines for good clinical laboratory practice: bridging operations
between research and clinical research laboratories. J. Pharm. Biomed. Anal.

2008;46:18-29.
32. HortonH, Thomas EP, Stucky JA, Frank I, Moodie Z, HuangY, Chiu YL, McElrathMJ, De
Rosa SC. Optimization and validation of an 8-color intracellular cytokine staining (ICS)
assay to quantify antigen-specific T cells induced by vaccination. J. Immunol. Methods
2007;323:39-54.
33. College of American, Pathologists. CAP 15189: Accreditation to the ISO 15189:2007
Standard. College of American Pathologists, Northfield, IL, 2008. Available at http://
www.cap.org.
34. International Organization for, Standardization. Medical Laboratories: Particular
Requirements for Quality and Competence. ISO-15189, 2007.
35. International Organization for, Standardization. General Requirements for the Competence
of Testing and Calibration Laboratories. ISO-17025, 2005.
36. Lemster B, Huang LL, Irish W, Woo J, Carroll PB, Abu-Elmagd K, Rilo HR, Johnson N,
Russell-Hall R, and Fung JJ. Influence of FK 506 (tacrolimus) on circulating CD4 þ T cells
expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple
sclerosis participating in an open label drug safety trial. Autoimmunity 1994;19(2):89: 98.